NCT05509010Recruiting
AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry
AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry (APOLLO)
Source: ClinicalTrials.gov · Last updated 19 Aug 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The overall aim is to build an AI driven national Platform for CT cOronary angiography for clinicaL and industriaL applicatiOns (APOLLO) for automated anonymization, reporting, Agatston scoring and plaque quantification in CAD. It is a "one-stop" platform spanning diagnosis to clinical management and prognosis, and aid in predicting pharmacotherapy response.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 8000 (estimated)
- First submitted
- 19 Apr 2022
- Start date
- 1 Oct 2021
- Primary completion date
- Dec 2027
- Lead sponsor
- National Heart Centre Singapore
- Diseases
- Coronary artery disease
- NCT number
- NCT05509010
What you commit to
- Study type: Observational
- Planned participants: 8000
- From 1 Oct 2021 to the primary completion date, Dec 2027
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concomitant participation in another clinical trial in which subject is subject to investigational drug or device
- Cardiac event and/or coronary revascularization (percutaneous coronary intervention (PCI) and/or coronary artery bypass grafting (CABG) and/or valvular repair/replacement prior to CTCA
Other illness
- Known complex congenital heart disease
- Known allergy to iodinated contrast agent
Age
- Non-cardiac illness with life expectancy \< 2 years
Other
- Individuals unable to provide informed consent
- Planned invasive angiography for reasons other than CAD
- Pregnancy
- Glomerular Filtration Rate ≤ 30mL/min
- Contraindications to beta blockers or nitroglycerin or adenosine
Who the study is looking for
- Age ≥21 years old
- Signed informed consent
- Clinically indicated for evaluation by CTCA
Age in the registry: 21 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Heart Centre Singapore Coordinator of this site? Confirm its status | Singapore | Singapore | Recruiting |
| National University Hospital Coordinator of this site? Confirm its status | Singapore | Singapore | Recruiting |
| Tan Tock Seng Hospital Coordinator of this site? Confirm its status | Singapore | Singapore | Recruiting |
Related publications
- Deep learning-based quantification of epicardial adipose tissue volume from non-contrast computed tomography images: a multi-centre study.Eur Heart J Digit Health · 2025 · PMID 41267847
This page is information, not medical advice. Discuss any trial with your doctor.